Phase 3 ACTT-3 Trial Reveals No Greater Benefit With Interferon Beta-1a Plus Remdesivir Versus Remdesivir Alone In Hospitalized Patients With COVID-19 Pneumonia

October 19, 2021

MedPage Today (10/18, Walker) reports, “Hospitalized patients with COVID-19 pneumonia recovered no faster when treated with interferon beta-1a and remdesivir (Veklury) as when treated with remdesivir alone, data from the phase III ACTT-3 trial found.” In...